id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2021-0031-0007,DEA,DEA-2021-0031,"Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I",Proposed Rule,,2024-04-11T04:00:00Z,2024,4,2024-04-11T04:00:00Z,2024-05-14T03:59:59Z,2024-05-03T19:54:22Z,2024-07694,0,0,09000064864cd92b
DEA-2021-0031-0001,DEA,DEA-2021-0031,"Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule I",Proposed Rule,,2021-12-07T05:00:00Z,2021,12,2021-12-07T05:00:00Z,,2021-12-08T16:07:57Z,2021-26263,0,0,0900006484ea7b00